Biotech startup String Bio has raises $20 million in Series B

0
347

Biotech startup String Bio has raised $20 million in its Series B round led by Woodside Technologies Pty Ltd. New and existing investors such as Ankur Capital, Dare Ventures, Redstart, Zenfold Ventures, and others have also participated in the round.

Exclusive: Shadowfax has raised the fresh funds at $600 million valuation

Through this investment, Vinod Kumar and Ezhil Subbain-led String Bio will build its ability to potentially abate greenhouse gases through the conversion of carbon into useful products.

The Bengaluru-based startup will strengthen its decarbonization impact my current investment and collaboration.

String Bio (Biotech Startup) is a technology platform that leverages advances in Biology, fermentation technology, Chemistry and process engineering to convert the energy in methane into diverse value-added products. The company enables products ranging from protein ingredients for nutrition, to innovative crop inputs, to products for biodegradable polymers.

Ensuredit raises $4.2 million in pre-Series

Recommended For You: